PharmaMar at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

PharmaMar takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 1066. Its program centres on extensive-stage small cell lung cancer. The discussion looks at how treatment can change the course of this disease and give patients more time.

OrganizationESMO 2026 Attendance
pharmamar.com
BiotechExhibitor
Spanish biopharmaceutical company developing and marketing marine-derived cancer medicines, including trabectedin and lurbinectedin.
Booth
Exhibiting at Booth 1066
Satellite
Sat Oct 24
18:30–20:00
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Sponsored session · with University of Turin
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from PharmaMar

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction